Event-Driven Stocks

GeneDx Holdings Corp.

WGSNasdaq

Healthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 2 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$427.5M$305.4M$202.6M$234.7M$212.2M$179.3M
Operating income−$13.1M−$23.2M−$180.6M−$667.7M−$446.1M−$242.0M
Net income−$21.0M−$52.3M−$175.8M−$549.0M−$245.4M−$241.3M
Total assets$523.7M$419.4M$418.8M$490.9M$554.1M$251.6M
Total liabilities$215.5M$174.1M$190.7M$237.2M$166.0M$247.3M
Equity$308.2M$245.2M$228.0M$253.7M$388.1M−$330.1M
EPS (diluted)$-0.73$-1.94$-7.23$-53.63$-2.27$-47036.00
Shares out.28.1M26.1M798.2M245.0M108.1M5,131

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−3.1%
Net margin
−4.9%
Return on equity
−6.8%
Return on assets
−4.0%
Return on capital (ROCE)
−3.2%
Liabilities / assets
41.2%
Debt / equity
0.70×
Book value / share
$10.98
Revenue growth (YoY)
40.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-5.22distress
Accruals / assets
−10.4%clean
Beneish M-Score
-2.31normal
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
75
/ 100
Profitability 0Growth 100Catalyst 100Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 2 warning● 4 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
11 acquisitions0 disposals3 open-market buy(s)net +522,877 shares · last 11
InsiderDateTypeSharesPrice
Casdin Capital, LlcDirectorMay 18, 2026Buy175,000$42.55
Meister Keith A.DirectorMay 13, 2026Buy94,074$38.82
Meister Keith A.DirectorMay 7, 2026Buy128,181$35.46
Stueland KatherineOfficer — CHIEF EXECUTIVE OFFICERApr 29, 2026Option exercise3,874$0.00
Feeley KevinOfficer — CHIEF FINANCIAL OFFICERApr 29, 2026Option exercise754$0.00
Feeley KevinOfficer — CHIEF FINANCIAL OFFICERMar 26, 2026Option exercise16,250$0.00
Stueland KatherineOfficer — CHIEF EXECUTIVE OFFICERMar 26, 2026Option exercise80,000$0.00
Stueland KatherineOfficer — CHIEF EXECUTIVE OFFICERMar 15, 2026Option exercise11,921$0.00
Feeley KevinOfficer — CHIEF FINANCIAL OFFICERMar 15, 2026Option exercise3,815$0.00
Feeley KevinOfficer — CHIEF FINANCIAL OFFICERMar 9, 2026Option exercise2,462$0.00
Stueland KatherineOfficer — CHIEF EXECUTIVE OFFICERMar 9, 2026Option exercise6,546$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20264.9M1.7+16.8%
Apr 30, 20264.2M7.8+6.6%
Apr 15, 20264.0M6.1+0.5%
Mar 31, 20263.9M5.3+2.1%
Mar 13, 20263.9M4.6+10.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)